Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...

PARIS, France I July 21, 2025 I Corteria Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of transformative ...

Rosie O'Donnell, who's been opening up about her weight-loss journey online, celebrated her progress in a new post.

Everyone aspires to live a healthy life. The catch is that health is a moving target. It’s a challenge that changes as people ...

Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...